Results from the BIO Convention 2013 Meeting Analysis of Therapeutic In/Out Licensors
Unknown file type. Enclosure URL IS: - http://www.biotech-now.org/wp-content/uploads/2013/04/BIO2013-1x1-Meeting-Analysis-of-In-vs-Out-licensors.pdf
Summary: BIO’s results from the BIO 2013 Convention 1×1 meeting analysis conducted to identify trends and intentions of therapeutic in-licensors and out-licensors were released today. The analysis looked at the meeting activity of 180 in-licensors attending the Chicago conference in terms of what therapeutic areas and stages of development were in highest demand. Of the 804 drug R&D companies, companies in Phase I/Rare Disease came out ahead as a group, with an average of >17 meetings/company. This was followed by Phase Read More
